BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schürmann GM, Bishop AE, Facer P, Vecchio M, Lee JC, Rampton DS, Polak JM. Increased expression of cell adhesion molecule P-selectin in active inflammatory bowel disease. Gut. 1995;36:411-418. [PMID: 7535284 DOI: 10.1136/gut.36.3.411] [Cited by in Crossref: 73] [Cited by in F6Publishing: 67] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Sands BE. Biologic therapy for inflammatory bowel disease. Inflamm Bowel Dis 1997;3:95-113. [DOI: 10.1002/ibd.3780030206] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
2 Duchmann R, Zeitz M. Crohn's Disease: Current Pathogenetic Paradigms. Mucosal Immunology. Elsevier; 2005. pp. 1265-85. [DOI: 10.1016/b978-012491543-5/50076-0] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
3 Iwashita E, Iwai A, Sawazaki Y, Matsuda K, Miyahara T, Itoh K. Activation of microvascular endothelial cells in active ulcerative colitis and detection of inducible nitric oxide synthase. J Clin Gastroenterol. 1998;27 Suppl 1:S74-S79. [PMID: 9872501 DOI: 10.1097/00004836-199800001-00012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
4 Seyfarth H, Koksch M. Fibrinogen receptor antagonists induce conformational changes of the human platelet glycoprotein IIb. Cytometry 2004;62B:14-24. [DOI: 10.1002/cyto.b.20026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
5 Sun FF, Lai PS, Yue G, Yin K, Nagele RG, Tong DM, Krzesicki RF, Chin JE, Wong PY. Pattern of cytokine and adhesion molecule mRNA in hapten-induced relapsing colon inflammation in the rat. Inflammation. 2001;25:33-45. [PMID: 11293664 DOI: 10.1023/a:1007023611478] [Cited by in Crossref: 52] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
6 Angiari S. Selectin-mediated leukocyte trafficking during the development of autoimmune disease. Autoimmunity Reviews 2015;14:984-95. [DOI: 10.1016/j.autrev.2015.06.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
7 Vainer B, Nielsen OH. Changed colonic profile of P-selectin, platelet-endothelial cell adhesion molecule-1 (PECAM-1), intercellular adhesion molecule-1 (ICAM-1), ICAM-2, and ICAM-3 in inflammatory bowel disease. Clin Exp Immunol. 2000;121:242-247. [PMID: 10931137 DOI: 10.1046/j.1365-2249.2000.01296.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 2.6] [Reference Citation Analysis]
8 Laroux FS, Grisham MB. Immunological basis of inflammatory bowel disease: role of the microcirculation. Microcirculation. 2001;8:283-301. [PMID: 11687942 DOI: 10.1111/j.1549-8719.2001.tb00177.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
9 Korzenik JR. IBD: A vascular disorder? the case for heparin therapy. Inflamm Bowel Dis 1997;3:87-94. [DOI: 10.1002/ibd.3780030205] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
10 Neuman MG. Immune dysfunction in inflammatory bowel disease. Transl Res. 2007;149:173-186. [PMID: 17383591 DOI: 10.1016/j.trsl.2006.11.009] [Cited by in Crossref: 150] [Cited by in F6Publishing: 139] [Article Influence: 10.7] [Reference Citation Analysis]
11 Sands BE. Biologic Therapy for Inflammatory Bowel Disease: . Inflammatory Bowel Diseases 1997;3:95-113. [DOI: 10.1097/00054725-199706000-00005] [Cited by in Crossref: 37] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
12 Iwaszkiewicz KS, Schneider JJ, Hua S. Targeting peripheral opioid receptors to promote analgesic and anti-inflammatory actions. Front Pharmacol 2013;4:132. [PMID: 24167491 DOI: 10.3389/fphar.2013.00132] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 6.4] [Reference Citation Analysis]
13 Deshpande N, Lutz AM, Ren Y, Foygel K, Tian L, Schneider M, Pai R, Pasricha PJ, Willmann JK. Quantification and monitoring of inflammation in murine inflammatory bowel disease with targeted contrast-enhanced US. Radiology. 2012;262:172-180. [PMID: 22056689 DOI: 10.1148/radiol.11110323] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 5.1] [Reference Citation Analysis]
14 Keyser FD, Elewaut D, Wever ND, Bensbaho K, Cuvelier C. The gut associated addressins: lymphocyte homing in the gut. Baillière's Clinical Rheumatology 1996;10:25-39. [DOI: 10.1016/s0950-3579(96)80004-5] [Cited by in Crossref: 8] [Article Influence: 0.3] [Reference Citation Analysis]
15 Fuller TF, Sattler B, Binder L, Vetterlein F, Ringe B, Lorf T. Reduction of severe ischemia/reperfusion injury in rat kidney grafts by a soluble P-selectin glycoprotein ligand. Transplantation. 2001;72:216-222. [PMID: 11477341 DOI: 10.1097/00007890-200107270-00008] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 1.8] [Reference Citation Analysis]
16 Wan MX, Riaz AA, Schramm R, Wang Y, Vestweber D, Menger MD, Thorlacius H. Leukocyte rolling is exclusively mediated by P-selectinin colonic venules. Br J Pharmacol 2002;135:1749-56. [PMID: 11934816 DOI: 10.1038/sj.bjp.0704638] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 1.5] [Reference Citation Analysis]
17 Okanishi H, Kagawa Y, Watari T. Expression of selectins and P-selectin glycoprotein ligand-1 in dogs with lymphocytic–plasmacytic enteritis. Veterinary Immunology and Immunopathology 2014;161:42-8. [DOI: 10.1016/j.vetimm.2014.06.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
18 Qiao L, Braunstein J, Golling M, Schürmann G, Autschbach F, Möller P, Meuer S. Differential regulation of human T cell responsiveness by mucosal versus blood monocytes. Eur J Immunol 1996;26:922-7. [DOI: 10.1002/eji.1830260430] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 1.4] [Reference Citation Analysis]
19 Kawachi S, Morise Z, Jennings SR, Conner E, Cockrell A, Laroux SF, Chervenak RP, Wolcott M, van der Heyde H, Gray L, Feng L, Granger ND, Specian RA, Grisham MB. Cytokine and Adhesion Molecule Expression in SCID Mice Reconstituted with CD4+ T Cells: . Inflammatory Bowel Diseases 2000;6:171-80. [DOI: 10.1097/00054725-200008000-00003] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 1.5] [Reference Citation Analysis]
20 Debbage P, Thurner GC. Nanomedicine Faces Barriers. Pharmaceuticals 2010;3:3371-416. [DOI: 10.3390/ph3113371] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
21 Dagia NM, Harii N, Meli AE, Sun X, Lewis CJ, Kohn LD, Goetz DJ. Phenyl Methimazole Inhibits TNF-α-Induced VCAM-1 Expression in an IFN Regulatory Factor-1-Dependent Manner and Reduces Monocytic Cell Adhesion to Endothelial Cells. J Immunol 2004;173:2041-9. [DOI: 10.4049/jimmunol.173.3.2041] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 2.5] [Reference Citation Analysis]
22 Granger DN, Grisham MB, Kevil CG. Recruitment of Inflammatory and Immune Cells in the Gut: Physiology and Pathophysiology. Physiology of the Gastrointestinal Tract. Elsevier; 2006. pp. 1137-62. [DOI: 10.1016/b978-012088394-3/50049-0] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
23 Tarlton NJ, Green CM, Lazarus NH, Rott L, Wong AP, Abramson ON, Bremer M, Butcher EC, Abramson T. Plasmablast frequency and trafficking receptor expression are altered in pediatric ulcerative colitis. Inflamm Bowel Dis 2012;18:2381-91. [PMID: 22488927 DOI: 10.1002/ibd.22962] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
24 Goggins MG, Goh J, O’Connell MA, Weir DG, Kelleher D, Mahmud N. Soluble adhesion molecules in inflammatory bowel disease. Ir J Med Sci. 2001;170:107-111. [PMID: 11491044 DOI: 10.1007/bf03168821] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
25 Korzenik JR. IBD: A Vascular Disorder? The Case for Heparin Therapy: . Inflammatory Bowel Diseases 1997;3:87-94. [DOI: 10.1097/00054725-199706000-00004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
26 Göke M, Hoffmann JC, Evers J, Krüger H, Manns MP. Elevated serum concentrations of soluble selectin and immunoglobulin type adhesion molecules in patients with inflammatory bowel disease. J Gastroenterol 1997;32:480-6. [DOI: 10.1007/bf02934086] [Cited by in Crossref: 41] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
27 Rijcken EM, Laukoetter MG, Anthoni C, Meier S, Mennigen R, Spiegel HU, Bruewer M, Senninger N, Vestweber D, Krieglstein CF. Immunoblockade of PSGL-1 attenuates established experimental murine colitis by reduction of leukocyte rolling. Am J Physiol Gastrointest Liver Physiol 2004;287:G115-24. [PMID: 15001428 DOI: 10.1152/ajpgi.00207.2003] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 2.6] [Reference Citation Analysis]
28 Ruchaud-Sparagano MH, Malaud E, Gayet O, Chignier E, Buckland R, McGregor JL. Mapping the epitope of a functional P-selectin monoclonal antibody (LYP20) to a short complement-like repeat (SCR 4) domain: use of human-mouse chimaera and homologue-replacement mutagenesis. Biochem J 1998;332 ( Pt 2):309-14. [PMID: 9601057 DOI: 10.1042/bj3320309] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
29 Kayo S, Ikura Y, Suekane T, Shirai N, Sugama Y, Ohsawa M, Adachi K, Watanabe K, Nakamura S, Fujiwara Y, Oshitani N, Higuchi K, Maeda K, Hirakawa K, Arakawa T, Ueda M. Close association between activated platelets and neutrophils in the active phase of ulcerative colitis in humans. Inflamm Bowel Dis. 2006;12:727-735. [PMID: 16917228 DOI: 10.1097/00054725-200608000-00009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
30 Tanida S, Mizoshita T, Mizushima T, Sasaki M, Shimura T, Kamiya T, Kataoka H, Joh T. Involvement of oxidative stress and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in inflammatory bowel disease. J Clin Biochem Nutr. 2011;48:112-116. [PMID: 21373262 DOI: 10.3164/jcbn.10-41] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
31 Koenecke C, Förster R. CCR9 and inflammatory bowel disease. Expert Opinion on Therapeutic Targets 2009;13:297-306. [DOI: 10.1517/14728220902762928] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
32 Anthoni C, Laukoetter MG, Rijcken E, Vowinkel T, Mennigen R, Müller S, Senninger N, Russell J, Jauch J, Bergmann J. Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitis. Am J Physiol Gastrointest Liver Physiol. 2006;290:G1131-G1137. [PMID: 16423918 DOI: 10.1152/ajpgi.00562.2005] [Cited by in Crossref: 65] [Cited by in F6Publishing: 57] [Article Influence: 4.3] [Reference Citation Analysis]
33 Vowinkel T, Mori M, Krieglstein CF, Russell J, Saijo F, Bharwani S, Turnage RH, Davidson WS, Tso P, Granger DN. Apolipoprotein A-IV inhibits experimental colitis. J Clin Invest. 2004;114:260-269. [PMID: 15254593 DOI: 10.1172/jci200421233] [Cited by in Crossref: 104] [Article Influence: 6.1] [Reference Citation Analysis]
34 Ko JK, Lam FY, Cheung AP. Amelioration of experimental colitis by Astragalus membranaceus through anti-oxidation and inhibition of adhesion molecule synthesis. World J Gastroenterol. 2005;11:5787-5794. [PMID: 16270386 DOI: 10.3748/wjg.v11.i37.5787] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 46] [Article Influence: 3.1] [Reference Citation Analysis]
35 Van Rees EP, Palmen MJ, Van De Goot FR, Macher BA, Dieleman LA. Leukocyte migration in experimental inflammatory bowel disease. Mediators Inflamm 1997;6:85-93. [PMID: 18472841 DOI: 10.1080/09629359791776] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
36 Norman MU, Hickey MJ. Mechanisms of lymphocyte migration in autoimmune disease. Tissue Antigens 2005;66:163-72. [PMID: 16101827 DOI: 10.1111/j.1399-0039.2005.00434.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
37 Mori M, Salter JW, Vowinkel T, Krieglstein CF, Stokes KY, Granger DN. Molecular determinants of the prothrombogenic phenotype assumed by inflamed colonic venules. Am J Physiol Gastrointest Liver Physiol. 2005;288:G920-G926. [PMID: 15550557 DOI: 10.1152/ajpgi.00371.2004] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
38 Israeli E, Goldin E, Fishman S, Konikoff F, Lavy A, Chowers Y, Melzer E, Lahat A, Mahamid M, Shirin H. Oral administration of non-absorbable delayed release 6-mercaptopurine is locally active in the gut, exerts a systemic immune effect and alleviates Crohn’s disease with low rate of side effects: results of double blind Phase II clinical trial. Clin Exp Immunol. 2015;181:362-372. [PMID: 25846055 DOI: 10.1111/cei.12640] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
39 Oommen AM, Somaiya N, Vijayan J, Kumar S, Venkatachalam S, Joshi L. GlycoGAIT: A web database to browse glycogenes and lectins under gastric inflammatory diseases. J Theor Biol 2016;406:93-8. [PMID: 27436239 DOI: 10.1016/j.jtbi.2016.07.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
40 Koutroubakis IE, Theodoropoulou A, Xidakis C, Sfiridaki A, Notas G, Kolios G, Kouroumalis EA. Association between enhanced soluble CD40 ligand and prothrombotic state in inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2004;16:1147-1152. [PMID: 15489574 DOI: 10.1097/00042737-200411000-00011] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
41 Beltzer A, Kaulisch T, Bluhmki T, Schoenberger T, Stierstorfer B, Stiller D. Evaluation of Quantitative Imaging Biomarkers in the DSS Colitis Model. Mol Imaging Biol 2016;18:697-704. [DOI: 10.1007/s11307-016-0937-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
42 Gurbel PA, Kereiakes DJ, Dalesandro MR, Bahr RD, O'connor CM, Serebruany VL. Role of soluble and platelet-bound P-selectin in discriminating cardiac from noncardiac chest pain at presentation in the emergency department. American Heart Journal 2000;139:320-8. [DOI: 10.1016/s0002-8703(00)90242-4] [Cited by in Crossref: 52] [Article Influence: 2.5] [Reference Citation Analysis]
43 Mochizuki M, Tsuchie Y, Yamada N, Miyake Y, Osawa T. Effect of sesame lignans on TNF-alpha-induced expression of adhesion molecules in endothelial cells. Biosci Biotechnol Biochem 2010;74:1539-44. [PMID: 20699585 DOI: 10.1271/bbb.100095] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
44 Wang H, Machtaler S, Bettinger T, Lutz AM, Luong R, Bussat P, Gambhir SS, Tranquart F, Tian L, Willmann JK. Molecular imaging of inflammation in inflammatory bowel disease with a clinically translatable dual-selectin-targeted US contrast agent: comparison with FDG PET/CT in a mouse model. Radiology. 2013;267:818-829. [PMID: 23371306 DOI: 10.1148/radiol.13122509] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 6.1] [Reference Citation Analysis]
45 Porcher C, Baldo M, Henry M, Orsoni P, Julé Y, Ward SM. Deficiency of interstitial cells of Cajal in the small intestine of patients with Crohn's disease. Am J Gastroenterol 2002;97:118-25. [PMID: 11808934 DOI: 10.1111/j.1572-0241.2002.05430.x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 3.8] [Reference Citation Analysis]
46 Sakhalkar HS, Dalal MK, Salem AK, Ansari R, Fu J, Kiani MF, Kurjiaka DT, Hanes J, Shakesheff KM, Goetz DJ. Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo. Proc Natl Acad Sci U S A 2003;100:15895-900. [PMID: 14668435 DOI: 10.1073/pnas.2631433100] [Cited by in Crossref: 120] [Cited by in F6Publishing: 114] [Article Influence: 6.7] [Reference Citation Analysis]
47 Vowinkel T, Mori M, Krieglstein CF, Russell J, Saijo F, Bharwani S, Turnage RH, Davidson WS, Tso P, Granger DN. Apolipoprotein A-IV inhibits experimental colitis. J Clin Invest. 2004;114:260-269. [PMID: 15254593 DOI: 10.1172/jci21233] [Cited by in Crossref: 4] [Cited by in F6Publishing: 62] [Article Influence: 0.2] [Reference Citation Analysis]
48 Matos I, Bento AF, Marcon R, Claudino RF, Calixto JB. Preventive and therapeutic oral administration of the pentacyclic triterpene α,β-amyrin ameliorates dextran sulfate sodium-induced colitis in mice: the relevance of cannabinoid system. Mol Immunol 2013;54:482-92. [PMID: 23454360 DOI: 10.1016/j.molimm.2013.01.018] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
49 Folch-Puy E, García-Movtero A, Iovanna JL, Dagorn JC, Prats N, Vaccaro MI, Closa D. The pancreatitis-associated protein induces lung inflammation in the rat through activation of TNFalpha expression in hepatocytes. J Pathol. 2003;199:398-408. [PMID: 12579542 DOI: 10.1002/path.1307] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
50 Bamford KB. Chronic gastrointestinal inflammation. FEMS Immunol Med Microbiol 1999;24:161-8. [PMID: 10378415 DOI: 10.1111/j.1574-695X.1999.tb01277.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
51 Naito Y, Takagi T, Yoshikawa T. Molecular fingerprints of neutrophil-dependent oxidative stress in inflammatory bowel disease. J Gastroenterol. 2007;42:787-798. [PMID: 17940831 DOI: 10.1007/s00535-007-2096-y] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 4.9] [Reference Citation Analysis]
52 Sakhalkar HS, Hanes J, Fu J, Benavides U, Malgor R, Borruso CL, Kohn LD, Kurjiaka DT, Goetz DJ. Enhanced adhesion of ligand‐conjugated biodegradable particles to colitic venules. FASEB j 2005;19:1-18. [DOI: 10.1096/fj.04-2668fje] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
53 Gu P, Theiss A, Han J, Feagins LA. Increased Cell Adhesion Molecules, PECAM-1, ICAM-3, or VCAM-1, Predict Increased Risk for Flare in Patients With Quiescent Inflammatory Bowel Disease. J Clin Gastroenterol 2017;51:522-7. [PMID: 27552332 DOI: 10.1097/MCG.0000000000000618] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
54 Eksteen B, Liaskou E, Adams DH. Lymphocyte homing and its role in the pathogenesis of IBD. Inflamm Bowel Dis 2008;14:1298-312. [PMID: 18393377 DOI: 10.1002/ibd.20453] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
55 Wéra O, Lecut C, Servais L, Hego A, Delierneux C, Jiang Z, Keutgens A, Evans RJ, Delvenne P, Lancellotti P, Oury C. P2X1 ion channel deficiency causes massive bleeding in inflamed intestine and increases thrombosis. J Thromb Haemost 2020;18:44-56. [PMID: 31448510 DOI: 10.1111/jth.14620] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
56 Elewaut D, De Keyser F, Cuvelier C, Lazarovits AI, Mielants H, Verbruggen G, Sas S, Devos M, Veys EM. Distinctive activated cellular subsets in colon from patients with Crohn's disease and ulcerative colitis. Scand J Gastroenterol 1998;33:743-8. [PMID: 9712239 DOI: 10.1080/00365529850171693] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 0.8] [Reference Citation Analysis]
57 Bendjelloul F, Rossmann P, Malý P, Mandys V, Jirkovská M, Prokesová L, Tucková L, Tlaskalová-Hogenová H. Detection of ICAM-1 in experimentally induced colitis of ICAM-1-deficient and wild-type mice: an immunohistochemical study. Histochem J 2000;32:703-9. [PMID: 11254085 DOI: 10.1023/a:1004191825644] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
58 Folwaczny C, Loeschke K, Schnettler D, Jäger G, Wiebecke B, Hoelscher M, Sauer T, König A, Endres SP, Fricke H. Endothelial cell autoantibodies are a marker of disease susceptibility in inflammatory bowel disease but apparently not linked to persistent measles virus infection. Clin Immunol 2000;95:197-202. [PMID: 10866126 DOI: 10.1006/clim.2000.4867] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
59 Ley K. Functions of selectins. Results Probl Cell Differ 2001;33:177-200. [PMID: 11190674 DOI: 10.1007/978-3-540-46410-5_10] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 1.7] [Reference Citation Analysis]
60 Almon E, Khoury T, Drori A, Gingis-Velitski S, Alon S, Chertkoff R, Mushkat M, Shaaltiel Y, Ilan Y. An oral administration of a recombinant anti-TNF fusion protein is biologically active in the gut promoting regulatory T cells: Results of a phase I clinical trial using a novel oral anti-TNF alpha-based therapy. J Immunol Methods 2017;446:21-9. [PMID: 28392436 DOI: 10.1016/j.jim.2017.03.023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
61 Patten DA, Shetty S. More Than Just a Removal Service: Scavenger Receptors in Leukocyte Trafficking. Front Immunol 2018;9:2904. [PMID: 30631321 DOI: 10.3389/fimmu.2018.02904] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
62 Murthy S, Flanigan A, Osborne BJ, Murthy NS. Inflammatory bowel diseases: a new wave of therapy. Expert Opinion on Therapeutic Patents 2005;8:785-818. [DOI: 10.1517/13543776.8.7.785] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
63 Belmiro CL, Castelo-Branco MT, Melim LM, Schanaider A, Elia C, Madi K, Pavão MS, de Souza HS. Unfractionated heparin and new heparin analogues from ascidians (chordate-tunicate) ameliorate colitis in rats. J Biol Chem 2009;284:11267-78. [PMID: 19258310 DOI: 10.1074/jbc.M807211200] [Cited by in Crossref: 39] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
64 Broedl UC, Schachinger V, Lingenhel A, Lehrke M, Stark R, Seibold F, Göke B, Kronenberg F, Parhofer KG, Konrad-zerna A. Apolipoprotein A-IV Is an Independent Predictor of Disease Activity in Patients with Inflammatory Bowel Disease: . Inflammatory Bowel Diseases 2007;13:391-7. [DOI: 10.1002/ibd.20078] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
65 Vainer B. Role of Cell Adhesion Molecules in Inflammatory Bowel Diseases. Scandinavian Journal of Gastroenterology 2009;32:401-10. [DOI: 10.3109/00365529709025072] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
66 Theodoratou E, Campbell H, Ventham NT, Kolarich D, Pučić-Baković M, Zoldoš V, Fernandes D, Pemberton IK, Rudan I, Kennedy NA, Wuhrer M, Nimmo E, Annese V, McGovern DP, Satsangi J, Lauc G. The role of glycosylation in IBD. Nat Rev Gastroenterol Hepatol 2014;11:588-600. [PMID: 24912389 DOI: 10.1038/nrgastro.2014.78] [Cited by in Crossref: 82] [Cited by in F6Publishing: 73] [Article Influence: 11.7] [Reference Citation Analysis]
67 Vainer B. Intercellular adhesion molecule-1 (ICAM-1) in ulcerative colitis: presence, visualization, and significance. APMIS Suppl 2010;:1-43. [PMID: 20653648 DOI: 10.1111/j.1600-0463.2010.02647.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]